Molecule Information
General Information of the Molecule (ID: Mol01992)
Name |
Transcription factor PDR1 (PDR1)
,Saccharomyces cerevisiae
|
||||
---|---|---|---|---|---|
Synonyms |
PDR1; AMY1; ANT1; BOR2; CYH3; NRA2; SMR2; TIL1; TPE1; TPE3; YGL013C
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
PDR1
|
||||
Gene ID | |||||
Sequence |
MRGLTPKNGVHIETGPDTESSADSSNFSTGFSGKIRKPRSKVSKACDNCRKRKIKCNGKF
PCASCEIYSCECTFSTRQGGARIKNLHKTSLEGTTVQVKEETDSSSTSFSNPQRCTDGPC AVEQPTKFFENFKLGGRSSGDNSGSDGKNDDDVNRNGFYEDDSESQATLTSLQTTLKNLK EMAHLGTHVTSAIESIELQISDLLKRWEPKVRTKELATTKFYPNKSIETQLMKNKYCDVV HLTRYAAWSNNKKDQDTSSQPLIDEIFGLYSPFQFLSLQGIGKCFQNYRSKSKCEIFPRT AKETIYIMLRFFDVCFHHINQGCVSIANPLENYLQKMNLLPSTPSSISSAGSPNTAHTKS HVALVINHLPQPFVRNITGISNSELLSEMNNDISMFGILLKMLDMHKNSYQNFLMEITSN PSVAKNTQSIDVLQEFIHYCQAGEALIALCYSYYNSTLYNYVDFTCDITHLEQLLYFLDL LFWLSEIYGFEKVLNVAVHFVSRVGLSRWEFYVGLDENFAERRRNLWWKAFYFEKTLASK LGYPSNIDDSKINCLLPKNFRDVGFLDNRDFIENVHLVRRSEAFDNMCISDLKYYGELAV LQIVSHFSSSVLFNEKFTSIRNTSKPSVVREKLLFEVLEIFNETEMKYDAIKEQTGKLFD IAFSKDSTELKVSREDKIMASKFVLFYEHHFCRMVNESDNIVARLCVHRRPSILIENLKI YLHKIYKSWTDMNKILLDFDNDYSVYRSFAHYSISCIILVSQAFSVAEFIKVNDVVNMIR VFKRFLDIKIFSENETNEHVFNSQSFKDYTRAFSFLTIVTRIMLLAYGESSSTNLDVISK YIDENAPDLKGIIELVLDTNSCAYRFLLEPVQKSGFHLTVSQMLKNRKFQEPLMSNEDNK QMKHNSGKNLNPDLPSLKTGTSCLLNGIESPQLPFNGRSAPSPVRNNSLPEFAQLPSFRS LSVSDMINPDYAQPTNGQNNTQVQSNKPINAQQQIPTSVQVPFMNTNEINNNNNNNNNNK NNINNINNNNSNNFSATSFNLGTLDEFVNNGDLEDLYSILWSDVYPDS Click to Show/Hide
|
||||
Function |
Positive regulator of proteins involved in permeability. PDR1 and PDR3 jointly control the transcription level of both SNQ2 and PDR5.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
IDUE: Irregularity in Drug Uptake and Drug Efflux
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Cantharidin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Sacharomyces cerevisiae infection | [1] | |||
Resistant Disease | Sacharomyces cerevisiae infection [ICD-11: 1F29-1F2F] | |||
Resistant Drug | Cantharidin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | TRAMP-C2 cells | Prostate | Homo sapiens (Human) | CVCL_3615 |
Experiment for Molecule Alteration |
Western blot analysis; Fluorescence microscopy assay | |||
Experiment for Drug Resistance |
Spot dilution assay; Liquid media growth curve analysis; Colony forming unit (CFU) assay | |||
Mechanism Description | ABC transporter Pdr5 is required for cantharidin resistance in Saccharomyces cerevisiae. Cantharidin mediated upregulation of Pdr5 is majorly regulated by Pdr1, cantharidin induced the upregulation of both PDR1 and PDR5 genes., PDR5 is the main cantharidin resistance gene. |
Lovastatin
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Fungal infection | [2] | |||
Sensitive Disease | Fungal infection [ICD-11: 1F29-1F2F] | |||
Sensitive Drug | Lovastatin | |||
Molecule Alteration | Deletion mutation | Deleteion |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Saccharomyces cerevisiae strain Y12409 | 4932 | ||
Saccharomyces cerevisiae strain Y13029 | 4932 | |||
Saccharomyces cerevisiae strain Y13951 | 4932 | |||
Saccharomyces cerevisiae strain Y14381 | 4932 | |||
Sarcoma tissue | . | |||
Experiment for Molecule Alteration |
PCR | |||
Experiment for Drug Resistance |
Spot Test | |||
Mechanism Description | We investigated the susceptibility to lovastatin of S. cerevisiae strains deleted for PDR genes, responsible for exporting hydrophobic and amphiphilic drugs, such as lovastatin. Strains deleted for the genes tested, PDR1, PDR3, PDR5 and SNQ2, exhibited remarkably different phenotypes, with deletion of PDR5 causing the highest sensitivity to lovastatin. The study helped clarifying which pdr mutants to use in studies of physiological actions of statins in yeast. | |||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Fungal infection | [2] | |||
Sensitive Disease | Fungal infection [ICD-11: 1F29-1F2F] | |||
Sensitive Drug | Lovastatin | |||
Molecule Alteration | Deletion mutation | Deleteion |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Saccharomyces cerevisiae strain Y12409 | 4932 | ||
Saccharomyces cerevisiae strain Y13029 | 4932 | |||
Saccharomyces cerevisiae strain Y13951 | 4932 | |||
Saccharomyces cerevisiae strain Y14381 | 4932 | |||
Sarcoma tissue | . | |||
Experiment for Molecule Alteration |
PCR | |||
Experiment for Drug Resistance |
Spot Test | |||
Mechanism Description | We investigated the susceptibility to lovastatin of S. cerevisiae strains deleted for PDR genes, responsible for exporting hydrophobic and amphiphilic drugs, such as lovastatin. Strains deleted for the genes tested, PDR1, PDR3, PDR5 and SNQ2, exhibited remarkably different phenotypes, with deletion of PDR5 causing the highest sensitivity to lovastatin. The study helped clarifying which pdr mutants to use in studies of physiological actions of statins in yeast. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.